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To evaluate the adequacy of Diagnosis Related Group
prospective payment for percutaneous transluminal
coronary angioplasty, the clinical characteristics, length
of stay and hospital charges of all patients undergoing
this procedure at Boston's Beth Israel Hospital during
a 100 day period were examined. Of 113 such patients,
the 61 patients in whom nonelective dilation was per-
formed for unstable or postinfarction angina had a sig-
nificantly greater length of stay and total hospital charge
(10 ± 6 days and $14,700 ± $7,400, respectively) than
The high prevalence of coronary artery disease in the United
States and the rapid evolution of sophisticated procedures
for its management, such as cardiac catheterization and
coronary artery bypass surgery, have led cardiology and
cardiovascular surgery to account for approximately 25%
of total medical care costs (l). Percutaneous transluminal
coronary angioplasty (2) provides a new therapeutic alter-
native to conventional bypass surgery which may afford
significant cost savings in selected patients. Between 1977
and late 1981, however, fewer than 3,500 cases had been
performed worldwide. Coronary angioplasty was considered
an investigational therapy for use in a narrowly defined
subgroup of patients who had medically refractory angina
due to single vessel coronary artery disease and who ac-
counted for fewer than 10% of the 170,000 patients undergo-
ing bypass operations annually during that period. Accord-
ingly, the Diagnosis Related Group (DRG) payment system,
which was based on a sample of Medicare patients during
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did the 52 patients in whom elective dilation was per-
formed (6 ± 5 days and $8,500 ± $4,700, respectively,
p < 0.0001). Under the current prospective payment
system, however, these two groups of patients would
have been placed in the same Diagnosis Related Group,
and would have thus commanded equal institutional
reimbursement. One potential revision of the payment
system is presented to help to deal with this disparity.
(J Am Coil CardioI1986;8:784-90)
1981 and was implemented in October 1983, included coro-
nary angioplasty under an otherwise seldom used surgical
category (DRG-108, cardiothoracic procedure, except valve
and coronary bypass) based on the preexisting ICD-9 code
36.°for "removal of coronary obstruction."
Over the past several years, accumulated experience and
the availability of improved equipment has broadened the
applicability of coronary angioplasty to a larger subset of
patients with symptomatic coronary artery disease, so that
the annual number of cases has grown to more than 50,000
(3). Despite this radical change in the application of coro-
nary angioplasty, there has been little change in its treatment
under the prospective payment system, which provides a
fixed payment for all patients undergoing angioplasty, re-
gardless of the need for other nonsurgical procedures (such
as diagnostic catheterization) during the angioplasty admis-
sion or the presence of other medical comorbidities (such
as unstable clinical status or acute myocardial infarction).
This contrasts with bypass surgery, in which two separate
codes (DRG-106, DRG-107) are provided to account for
patients who need both diagnostic catheterization and sur-
gery within the same admission. The only significant recent
change in the prospective payment system relating to coro-
nary angioplasty has been the recommendation by the Pro-
spective Payment Assessment Commission (Pro-PAC) in
April 1985 (4) that angioplasty be reassigned from DRG-
108 to DRG-112 (vascular procedures except major recon-
struction), which would be associated with a 53% reduction
0735-1097/86/$3.50
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in institutional reimbursement. In doing so, Pro-PAC stated
that " . . . reassigning coronary angioplasty to a more ap-
propriate diagnosis related group will remove financial in-
centives which may have existed to perform coronary an-
gioplasty when alternative therapy, either medical or surgical,
was preferable."
Because of an alternate system for hospital payment
(Chapter 372), hospitals in Massachusetts were exempt from
the prospective payment system until October 1985, re-
ceiving essentially fixed annual institutional reimbursement
independent of the "case-mix" treated. Coronary angio-
plasty in Massachusetts has thus developed under clinical
considerations in the absence of positive or negative finan-
cial incentives provided by Diagnosis Related Group reim-
bursement in other states. Immediately before conversion
to the Diagnosis Related Group payment system in Mas-
sachusetts, Beth Israel Hospital embarked on a prospective
100 day study (June I to September 15, 1985), both to
describe the status of coronary angioplasty under the existing
system and to evaluate the adequacy of Diagnosis Related
Group payment for angioplasty as currently practiced.
Methods
Study design. Boston's Beth Israel Hospital is a 460
bed acute care, not-for-profit institution that serves as a
major teaching hospital of Harvard Medical School. Clin-
ical, demographic and charge information were collected
on all patients who underwent an invasive procedure be-
tween June I and September 15, 1985. To allow awareness
of subsequent elective mechanical revascularization per-
formed as the consequence of diagnostic procedures during
the study period, each patient's clinical course was followed
through November 15, 1985. Because none of the four
angioplasty operators was compensated in relation to the
number of invasive procedures performed, individual fi-
nancial incentives did not influence the decision to perform
coronary angioplasty.
Parameters of patient care. Patients undergoing coro-
nary angioplasty electively were typically admitted to a gen-
eral medical unit 1 day before the scheduled procedures.
After dilation, the patients were observed overnight in a
cardiac intensive care unit, with continuous heparin infusion
and indwelling femoral artery and vein sheaths. These sheaths
were removed the following morning, and the patients were
transferred back to a general medical unit for 24 hours of
bed rest. Exercise testing and discharge from hospital were
generally performed on the day after sheath removal, for a
total hospital stay of 4 days in scheduled elective cases
without complications. Nonelective patients, defined as those
who required initial hospitalization on clinical grounds and
who could not be discharged until revascularization was
performed, were inserted into the catheterization and an-
gioplasty schedules on a "first available opening" basis,
and were cared for on either a medical floor or an intensive
care unit, as required by their clinical condition. Surgical
standby was always providetl for angioplasty procedures,
but no institutional or professional fees were assessed for
this service.
Data analysis. According to the Diagnosis Related Group
classification principle, each patient hospitalization in which
a coronary angioplasty procedure was performed was as-
signed to a single category (previously DRG-108, now DRG-
112), as long as no other surgical procedure such as coronary
bypass grafting was performed during that admission. Length
of stay and institutional charge data (exclusive of profes-
sional fees) were calculated for all such angioplasty admis-
sions, including those in which more than one nonsurgical
invasive procedure (that is, diagnostic catheterization fol-
lowed by a separate coronary angioplasty) was performed.
Patient data were entered on a DEC system 10 computer
using the PROPHET data base program (5). Statistical com-
parisons were made using the Mann-Whitney rank sum test,
with the signficance level p < 0.05. Group data are ex-
pressed as mean ± SD.
Results
Overall patient population. During the study period,
227 patients underwent initial diagnostic catheterization for
the evaluation of coronary artery disease. Of these 227 pa-
tients, 139 (61%) proceeded to revascularization, This was
performed using coronary artery bypass surgery in 77 pa-
tients and coronary angioplasty in 62 patients. Coronary
angioplasty thus accounted for 45% of the revascularization
procedures performed as the result of a diagnostic cathe-
terization during the study period. An additional 55 patients
underwent coronary angioplasty during this period, having
undergone a diagnostic catheterization at another institution
or during an admission before the study period. Thus, a
total of 117 patients underwent coronary angioplasty during
the study period, accounting for 35% of all catheterization
laboratory procedures.
The patients undergoing coronary angioplasty generally
had advanced clinical disability (Table 1). Of 117 patients,
54 (48%) were in New York Heart Association functional
class IV, and 36 (32%) were in class III. The remaining
patients were in class II (19 patients) or in class I (4 patients)
but had new onset unstable angina with a severe underlying
lesion or evidence of profound ischemia on exercise testing,
or both. Another index of clinical severity was the timing
of coronary angioplasty: because of scheduling constraints,
patients in stable condition are usually discharged after di-
agnostic catheterization and later readmitted for elective
coronary angioplasty. Clinical considerations, however,
required that 61% of the coronary angioplasty procedures
during the study period be performed within the same
hospitalization as the diagnostic catheterization, with a mean
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Table 1. Mean Length of Stay and Total Institutional Charges by Type of Procedure and Patient Subgroup
Length of Stay (days) Institutional Charge*
No. of
Patients Mean ± SO p Value Mean ± SD p Value
Coronary Angioplasty (without surgery)
Total
Elective
Nonelective
Unstable angina
Myocardial infarction
Functional class
I
II
111M
IIIBt
IV
Age <70 years
Age 2':70 years
Single vessel disease
Multivessel disease
Il3t
52
61
36
25
4 (3%)
19 (17%)
29 (26%)
7 (6%)
54 (48%)
89
24
86
27
8 ± 6
6 ± 5
10 ± 6 :::::=::=- 0.000 I
10 ± 7
12 ± 7
4 ± I
5±2>6 ± 3 0.0001
7 ± 4
II ± 7
7 + 5
13 ~ 9~ 0.002
8 ± 6 NS
9±7~
$11,900 ± 7,000
8,500 ± 4,700 ____
14,700 ± 7,400~ 0.0001
13,800 ± 7,300
20,000 ± 7,900
6,800 ± 1,200
7,400 ± 2,000>
8,500 ± 3,800
10,000 ± 4,200 0.0001
15,800 ± 7,800
10,900 ± 6,600~
15,400 ± 7,300 0.001
11,400 ± 6,900~ NS
13,100 ± 7,300
Elective
Nonelective
Unstable angina
Myocardial infarction
Myocardial infarction without catheterization
Diagnostic Catheterization (without angioplasty or surgery)
83 3 ± 2
69 10±6~ 0.0001
51 10 ± 7
18 13 ± II.=::::::==- 0.01262§ 10 ± 6
4,400 ± 11,000 >- 0.0001
12,800 ± 12,900
10,100 ± 5,400
19,500 ± 21,300~ 0.0001
8,200 ± 5,200
*Institution charge is rounded off to the nearest $100 (see text). t 113 angioplasty patients excluding the 2 patients who underwent emergency surgery
and the 2 patients who underwent elective surgery during the same hospitalization after unsuccessful angioplasty attempt, according to Prospective
Payment policy. tA = oral medication only; B = intravenous nitroglycerin; NS = not significant. §262 patients without catheterization procedure were
drawn from 309 consecutive patients admitted with acute myocardial infarction between January I and 15, 1985, rather than during the study period
itself (June I to September 15, 1985).
in-hospital waiting period of 3 ± 2 days for nonelective
coronary angioplasty. A similar pattern was evident among
the patients going on to bypass surgery, of whom 65%
proceeded to surgery within the same admission, with an
in-hospital waiting period of 5 ± 3 days for nonelective
bypass.
Consistent with the status of Beth Israel Hospital as a
tertiary care teaching institution, 30% of all patient admis-
sions for invasive cardiac procedures were the result of
transfers from other hospitals. Between patients referred for
initial diagnostic catheterization (38%), and patients referred
specifically for coronary angioplasty, 44 of the 117 coronary
angioplasty patients during the study period reached Beth
Israel through interhospital transfer. All of these transfer
patients had class III or IV anginal symptoms, and 49%
were receiving intravenous nitroglycerin infusion or in-
traaortic balloon counterpulsation, or both, at the time of
transfer.
Coronary angioplasty: indications and outcome. The
spectrum of indications for coronary angioplasty during the
study period reflects the broadened application of this tech-
nique in 1985. Most coronary angioplasty procedures were
single vessel dilations, but multivessel dilation was per-
formed in 29 (25%) of the 117 patients. Nine patients had
two coronary dilation procedures within a single admission,
because of staged multivessel dilation (six patients) or treat-
ment of early reclosure within 48 hours after the initial
dilation (three patients). Seven patients underwent coronary
angioplasty for treatment of late restenosis of a previously
dilated segment, whereas seven patients underwent angio-
plasty for treatment of recurrent angina after prior bypass
surgery. Twenty-five angioplasty procedures were per-
formed in patients with acute myocardial infarction, but only
6 of these represented acute interventions within the first 48
hours of infarction. The remaining 19 procedures were per-
formed for the treatment of postinfarction unstable angina.
These 25 patients represented 17% of the 151 patients with
acute myocardial infarction admitted during the study pe-
riod. The mean age of the group undergoing coronary an-
gioplasty (59 ± 12 years, range 33 to 85) was similar to
that of the group undergoing diagnostic catheterization
(61 ± 12 years, range 23 to 84) at our institution; 24 patients
undergoing angiop1asty were more than 70 years of age.
Coronary angioplasty was successful (stenosis reduction
greater than 30%, with a residual stenosis less than 50%)
in 106 (94%) of the 117 study patients, including 27 (93%)
of the 29 patients undergoing multivessel dilation. Two
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patients required emergent bypass surgery as a result of
abrupt vessel reclosure related to angioplasty, but recovered
uneventfully. Because the performance of surgery removes
a patient admission from the angioplasty Diagnosis Related
Group, the two patients who required emergency bypass
surgery and the two additional patients who remained in-
hospital for .ionemergent bypass surgery after unsuccessful
angioplasty were excluded from subsequent length of stay
and charge analysis. There were no in-hospital deaths among
patients undergoing elective coronary angioplasty, but I
(4%) of the 25 patients undergoing coronary angioplasty
after acute myocardial infarction died because of myocardial
rupture 24 hours after successful dilation of the left anterior
descending coronary artery.
Length of stay and overall charges. There was a pro-
gressive increase in length of stay and institutional charge
with increasing clinical severity, as reflected by either New
York Heart Association functional class or the need for a
nonelective dilation procedure (Table I) . Patients more than
70 years old also had a significantly longer length of stay
and a higher total charge than did patients undergoing an-
gioplasty without this comorbidity. Patients undergoing an-
gioplasty after acute myocardial infarction had the longest
length of stay and highest institutional charge . Exclusion of
the 25 patients with acute myocardial infarction, however,
did not eliminate the substantial difference in length of stay
or charges for nonelective as compared with elective dilation
procedures. There were no differences in length of stay or
hospital charge for single versus multi vessel dilation.
Discussion
Improvement in dilation equipment and technique has
helped to expand the clinical application of coronary an-
gioplasty. In addition to the patient with single vessel disease
who would otherwise have required bypass surgery, an in-
creasing number of patients with multi vessel coronary artery
disease, one or more total occlusions, advanced age or other
severe medical disabilities that might preclude bypass sur-
gery are now being considered for coronary dilation (6-16) .
At the other end of the spectrum, patients with milder clin-
ical symptoms who might previously have been managed
medically. are also increasingly being referred for coronary
angioplasty (17).
It is not clear how these broadened indications for coro-
nary angioplasty will affect health care costs. Much of the
attraction of coronary angioplasty as an alternative to bypass
surgery derives from its ability to provide effective revas-
cularization with an inherently lower cost and shorter period
of disability. In the simplest model, where institutional charges
for angioplasty are one-half to one-third of those for bypass
surgery, and 80 to 90% of angioplasty procedures are suc-
cessful, per patient savings up to 50% are possible (18-21).
In actuality. however, approximately 20% of patients de-
velop recurrent angina due to restenosis within the first year
after angioplasty, and require either repeat dilation or late
coronary artery bypass surgery, which partially erodes the
initial savings. While Reeder et al. (19) suggested that only
a 15% net savings may remain, their study was marked by
a high early and late bypass surgery rate, reflecting the state
of the art in 1979 to 1981. Other studies (20-21) suggest
that current angioplasty technique, which provides a higher
primary success rate and a lower need for late bypass sur-
gery, would yield a net savings of 30 to 40% over bypass
surgery in patients with single vessel coronary artery disease
(19,20).
These observations, however, do not necessarily apply
to the entire population currently being treated by coronary
angioplasty. Patients with multivessel coronary artery dis-
ease may have a higher restenosis rate, and a corresponding
increase in the need for late repeat angioplasty or bypass
surgery, or both (II). Angioplasty in mildly symptomatic
patients, who had not previously been considered candidates
for surgical revascularization, may waste substantial health
care dollars unless the engendered short-term costs are offset
by long-term health improvements resulting from applica-
tion of coronary angioplasty at an earlier disease stage. To
address these issues, long-term randomized clinical trials
will be needed to compare angioplasty, medical therapy and
bypass surgery from both clinical and economic perspec-
tives .
Charge differences within the current angioplasty
population. Pending the results of formal clinical trials
(which are now only in the design phase), it is clear that
angioplasty is already being applied more broadly to patients
with coronary artery disease than could have been imagined
when the Diagnosis Related Group prospective payment
system was designed. Within this population, our data sug-
gest that there is a wide discrepancy in length of stay and
institutional charge between "low-cost" elective angio-
plasty patients and "high-cost" nonelective angioplasty pa-
tients . Similar stratification of the patient population is also
possible using patient age, presence or absence of acute
myocardial infarction or more marked functional limitation
(Table I) . Under the current prospective payment system,
which classifies coronary angioplasty as a "surgical pro-
cedure ," all angioplasty patients are forced into a single
"appropriately valued" reimbursement category (Fig. IA) ,
regardless of any comorbidities (acute myocardial infarc-
tion, advanced age, unstable angina or the need for both
diagnostic and therapeutic procedures during the same ad-
mission) .
Although the institutional payment to Beth Israel Hospital
under DRG-112 is projected to be approximately $11,000
per angioplasty patient (including the teaching component),
the fact that this approximates our current average institu-
tional charge of $11,800 is based on the particular mix of
distinctively different classes of patients treated during the
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A The EXISting Cardiovascular DRG Scheme
o. R. Procedure
»->.Yes No
~ AcuteM~ Infarction
~ /Yes NO _________
(DRGsI03-120) I 1
I
DRG Discharged Cardiac
112 Alive Catheterization
PTCA Yef"No ~
r D~G Yes No123
B The Proposed Cardiovascular DRG Scheme
O. R. Procedure
YeS~NO~~ Coronary Artery DiseaseIr------"-~--, __________
DRGs 103-120 I Yes No~
Ac Myocardia I Infarction ?~g
Yes ---------------NO (Chest Pain)
X- ~bPrOC
(,/ ~ ~ed(a)
AMI with Cath AMI without ~Yes No
Procedure Procedure (b) '1I ----- ~ Non-catheterizedI ~~~ .... 1 Angina Pectoris
DRG 1 DRGsII-III DRG VIII
DRG
143
Chest
Pain
DRG
140
Angina
Pectoris
Atherosclerosis
Age>70
'1 and/or complications
DRG /'...
125 Yes No( 'I
DRG DRG
132 133
Complex
Diagnosis
YeS~No
(
DRG
124
Cardiovascular
Complication
YeS~No( '1
DRG DRG
121 122
Figure 1. A, The existing Diagnosis Related Group
(DRG)schemefor patientswithcardiovasculardisease,
showing coronary angioplasty (PTCA, DRG-112) and
the nine other nonsurgical categories. B, The proposed
DRG scheme showing the substitution of eight new
DRGs (I to VIII) based on whether an acute myocardial
infarction (AMI) occurred, whether a catheterization
procedure (CATH. LAB. PROC.) was performed, the
severity of illness (elective/nonelective admission or
functional class) and whether the procedure was a di-
agnostic catheterization (Diag. Cath.) or a coronary
angioplasty (PTCA). (a) No distinction is provided be-
tween diagnostic catheterization for coronary artery
disease versus valvular or other diagnoses. (b) The two
newcodes (DRG-I1 and -III) could be used to designate
different levels of comorbidity among noncatheterized
patients with acute myocardial infarction (see text).
AC = acute; O.R. = operative.
Elective
Admission
~
Dlog Coth. PTCA
DRG IV DRG V
Non - elective
Admission
~~
Diag. Coth. PTCA
DRG VI DRG VII
study period. As the proportion of patients with complex
conditions increases, which would be expected with the
increasing use of dilation after thrombolytic therapy in pa-
tients with acute myocardial infarction, the fixed payment
under DRG-112 will become progressively more inade-
quate, particularly if such clinical activity engenders addi-
tional expenses related to enlargement of catheterization
facilities or provision of additional surgical standby.
Proposal for severity stratification of angioplasty pa-
tients. The concept of using a single DRG code and a single
reimbursement for a particular procedure presumes a tightly
clustered distribution of charges/costs within that patient
population (22). When significant cost variation is identified
within a DRG code as the result of specific patient attributes,
stratification of reimbursement according to these attributes
becomes appropriate (23,24). Data supporting stratification
within other DRGs, as well as the clinical and economic
consequences of continued nonstratified reimbursement, have
recently been presented (25). We believe that our data con-
cerning coronary angioplasty document a need for severity
of illness stratification within DRG-112, and that either
functional capacity classification (New York Heart Asso-
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cianon functional class) or the type of admission (elec-
tive/nonelect ive), might be used as indicators of severity
within a revised DRG structure . Moreo ver , we believe that
such a revision of the coronary artery disease DRG category
could be achieved without increasing the 10 currently used
codes (Fig. IA).
Accordin g to our propo sal (Fig. IB), the three Diagnosis
Related Groups (DRG- 121, -122 and -123) that were used
for patient s with acute myocardial infarction would be re-
placed by one code for myocardial infarction patient s
undergoing catheterization or angioplasty (DRG-I), or both ,
and two codes (DRG-I1 and -III ) for patient s who do not
undergo a catheterization procedure but may have additional
comorbidity. This separation is based on our observations
in patients with acute myocardial infarct ion admitted to Beth
Israel Hospital between January I and June IS, 1985
(Ta ble I), of whom the 262 patients who did not undergo
catheteriza tion during hospitalization had a length of stay
of 10 :t 6 days, and a hospital charge of $8, 000 :t $5, 200.
In contrast, patient s with infarction undergoing only diag-
nostic catheterization during the study period had a length
of stay and institutional charge ( 13 ± I I days and $ 19, 500
± 2 1,300, respecti vely) comp arable with those of patients
undergoing angioplasty (Table I).
The remaining six Diagnosis Related Groups currentl y
used for patient s without myocardial infarction would be
revised , with the exception of DRG-143 (chest pain), which
would be unchan ged. Patients with coron ary artery disease
could be subgrouped by wheth er a cardiac catheterization
procedure was performed, by level of severity (using either
elective/nonelective , or New York Heart Association Clas-
sification criteria) and by whether coronary angioplasty (with
or without a separate diagnostic catheterization during the
same hospitalization), or only diagnostic catheterization,
was performed (DRG-IV to -VII) . Noncatheterized patients
with angina pectoris would be placed in the final Diagnosis
Related Group (DRG-VIII ).
Conclusions. By monitoring our clin ical use of coronary
angioplasty before the institution of Diagnosis Related Group
prospect ive payment in Massachusetts, we have documented
the expanding role that this procedure plays in the current
management of patients with coronary artery disease. Within
the limitations of a single institut ion study, using hospital
charge and length of stay as surroga tes for " true" costs,
we have identi fied nearly equal numbers of " high-cost" and
"low-cost" angioplasty patient s within the overall popu-
lation. Although only 32% of angioplasty patients in this
study were actuall y reimbur sed by Medicare , the likely ex-
tension of prospective payment system criteria and methods
to other payer schemes makes it increasi ngly important to
recognize severity stratifi cation within this population , if
major imbalances in reimbursement are to be avoided. Our
proposed revi sion of the card iovascular Diagnosis Related
Group scheme would be one possible solution to this prob-
lem , and warrant s further evaluation in additional centers .
We thank our angioplasty colleagues (Drs. Beverly Lorell, Raymond McKay
and Jul ian Aroesty), cardiac surgeons (Drs. Ronald Weintraub . Robert
Thurer and Robert Johnson) and the technica l and nursing staffs of the
Catheterization Laboratory and Coronary Care Unit, for the continued
support that has made this study possible .
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